| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.0005 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.36 |
0.0005 |
| mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
| mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.003 |
| mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.005 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.006 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.007 |
| mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.009 |